Patent ID: 11918608
Assignee: RECELLERATE, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 9:
10. The method of claim 9, wherein the additional therapeutic agent is furosemide, aclidinium, albuterol, arformoterol, beclomethasone, budesonide, ciclesonide, clenbuterol, corticosteroids, dexamethasone, fluticasone, formoterol, indacaterol, ipratropium bromide, levalbuterol, L-arginine, metaproterenol, mometasone, pirbuterol, salmeterol, sildenafil, tiotropium, and vilanterol, a cell, platelet-rich plasma, conditioned medium, or nasal strips.